from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0398c/-

LFCtreatmentdescriptionclass of inhibitor

0.178

Amikacinug/mL Amikacintranslation

-0.571

Cap5-10ug/mL Capreomycintranslation

-0.351

Rox10-50 ug/mL Roxithromycintranslation

-0.604

SM2-5 ug/mL Streptomycintranslation

0.225

Tet5-10 ug/mL Tetracyclinetranslation

1.086

Rif0.2-5ug/mL Rifampicintranscription

0.492

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.252

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.837

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.209

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.213

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.813

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

3.347

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.529

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.308

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-2.837

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.715

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-3.599

Nigericin50 uM Nigericinrespiration

0.874

TRC10-150 ug/mL Triclosanrespiration

-0.049

TRZ10-25 ug/mL Thioridazinerespiration

-1.570

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.247

menadione6-10 ug/mL Menadionerespiration

0.101

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.296

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.408

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.926

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.002

NRP_1Non-replicating persistence stage 1dosRassociated

-0.686

Amp0.2mg/mL AmpicillincellWall

0.471

Cephalexin20-100 ug/mL CephalexincellWall

-0.299

Cerulenin0.32-5 ug/mL CerulenincellWall

0.410

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.385

EMB10-20 ug/mL EthambutolcellWall

-0.231

Eta12-40 ug/mL EthionamidecellWall

-0.283

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.476

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.331

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.039

BZA0.12 mg/mL BenzamidearomaticAmides

0.050

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.462

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.042

H2O24 mM hydrogen peroxideDNAdamaging

-0.097

Levo10 ug/mL LevofloxacinDNAdamaging

-0.364

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.493

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.147

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.743

UVUV-irradiationDNAdamaging

0.254

ARP41-4 ug/mL Antitubercular compound ARP4?

0.252

Antimycin12.5-50 ug/mL Antimycin A?

-1.027

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.016

PA_110-50 ug/mL Antitubercular compound PA-1?

0.162

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.177

PA8240.2-2 ug/mL PA-824?

1.241

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.018

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.314

Verapamil50 uM Verapamil?

-2.979

mercaptoethanol2 mM 2-Mercaptoethanol?

0.028

methoxatin10-20 ug/mL Methoxatin?